Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/KIROMIC-BIOPHARMA-INC-113902312/news/Kiromic-BioPharma-gibt-die-Verabreichung-des-ersten-Patienten-in-der-Phase-1-Studie-zu-Deltacel-zur-45570763/?utm_source=whatsapp&utm_medium=social&utm_campaign=share